Latest Articles

Publication Date
Democrats introduce bill to give 12 days of paid leave for reproductive health. - Brut

Democrats introduce bill to give 12 days of paid leave for reproductive health. Brut

Published: June 1, 2026, 10:03 p.m.
Study Shows Radiotracer Demonstrates Potential to Treat Interstitial Lung Disease - Imaging Technology News

Study Shows Radiotracer Demonstrates Potential to Treat Interstitial Lung Disease Imaging Technology News

Published: June 1, 2026, 5:13 p.m.
Howard Stern Celebrates Robin Quivers Being Cancer-Free After 14 Years - TMZ

Howard Stern Celebrates Robin Quivers Being Cancer-Free After 14 Years TMZ

Published: June 1, 2026, 4:53 p.m.
ACC healthcare harm claims rejected at 26 times rate of standard claims - The Post

ACC healthcare harm claims rejected at 26 times rate of standard claims The Post

Published: June 1, 2026, 4 p.m.
ACC healthcare harm claims rejected at 26 times rate of standard claims - The Press

ACC healthcare harm claims rejected at 26 times rate of standard claims The Press

Published: June 1, 2026, 4 p.m.
Democrat Congresswoman Wants 12 Days Paid Leave to Kill Babies in Abortions - lifenews.com

Democrat Congresswoman Wants 12 Days Paid Leave to Kill Babies in Abortions lifenews.com

Published: June 1, 2026, 3 p.m.
Your Period Shouldn’t Ruin Your Week: Why Gen Z Gals Need to Rethink Menstrual Pain - ETV Bharat

Your Period Shouldn’t Ruin Your Week: Why Gen Z Gals Need to Rethink Menstrual Pain ETV Bharat

Published: June 1, 2026, 8:31 a.m.
Puxitatug Samrotecan Elicits High Response Rate in Select Endometrial Cancers - OncLive

Puxitatug Samrotecan Elicits High Response Rate in Select Endometrial Cancers OncLive

Published: May 30, 2026, 9:59 p.m.
Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer - OncLive

Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer OncLive

Published: May 30, 2026, 12:24 a.m.
Immunotherapy Addition Demonstrates Sustained Survival Benefits in - Bioengineer.org

Immunotherapy Addition Demonstrates Sustained Survival Benefits in Bioengineer.org

Published: May 29, 2026, 11:56 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!